VCM
RYTM icon

Voleon Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Voleon Capital Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,025
Closed -$538K – 901
2025
Q4 		$538K Sell
5,025
-21,872
-81% -$2.32M 0.01% 558
2025
Q3 		$2.72M Buy
+26,897
New +$2.5M 0.07% 277
2025
Q2 		– Sell
-13,819
Closed -$732K – 527
2025
Q1 		$732K Buy
+13,819
New +$767K 0.06% 233

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Voleon Capital Management's RYTM Position: Q1 2026 in Review

Voleon Capital Management sold out of Rhythm Pharmaceuticals (RYTM) in Q1 2026, closing a stake of 5,025 shares — an estimated $538K sold.

Voleon Capital Management first reported a position in RYTM in Q1 2025 and held it in 3 quarters. The position peaked at $2.72M in Q3 2025. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Voleon Capital Management reported no remaining Rhythm Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Voleon Capital Management sold 5,025 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $538K.
  • Voleon Capital Management first reported a position in Rhythm Pharmaceuticals in Q1 2025 and held it in 3 quarters.
  • Voleon Capital Management's Rhythm Pharmaceuticals position peaked at $2.72M in Q3 2025.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.